VASCULAR BIOGENICS LTD (VBLT)
IL0011327454 - Common Stock
| TTM (2023-6-30) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -15.96M | -32.30M | -29.92M | -24.23M | -19.40M | |||
| Depreciation Amortization | 357.00K | 1.06M | 1.26M | 1.19M | 1.22M | |||
| Change In Working Capital | -2.50M | -2.61M | 1.70M | -2.08M | 2.62M | |||
| Interest Paid | N/A | 0.00 | 2.00K | 10.00K | 20.00K | |||
| Other non cash items | 509.00K | 2.26M | 1.98M | 1.73M | 2.47M | |||
| OPERATING CASH FLOW | -17.59M | -31.59M | -24.98M | -23.38M | -13.09M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | 31.00K | -812.00K | -1.47M | -50.00K | -70.00K | |||
| Other Investing Activity | 26.29M | 28.11M | -14.02M | 9.94M | -6.03M | |||
| INVESTING CASH FLOW | 26.32M | 27.30M | -15.49M | 9.89M | -6.10M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | N/A | 0.00 | -104.00K | -390.00K | -360.00K | |||
| Stock Issued/Repurchased | N/A | 22.00K | 51.41M | 17.46M | 0.00 | |||
| Other Financing Activity | N/A | 0.00 | -2.20M | N/A | N/A | |||
| FINANCING CASH FLOW | N/A | 22.00K | 49.11M | 17.07M | -360.00K | |||
| Exchange Rate Effect | 96.00K | -47.00K | 15.00K | 180.00K | 140.00K | |||
| CHANGE IN CASH | 8.84M | -4.32M | 8.65M | 3.76M | -19.41M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -17.59M | -31.59M | -24.98M | -23.38M | -13.09M | |||
| Capital Expenditure | 31.00K | -812.00K | -1.47M | -50.00K | -70.00K | |||
| FREE CASH FLOW | -17.56M | -32.41M | -26.45M | -23.43M | -13.16M | |||
All data in USD